Abstract
HomeRadiology: Imaging CancerVol. 5, No. 2 PreviousNext CommentaryPretherapy Ferumoxytol-enhanced MRI for Metastatic Breast Cancer: A New Approach for Predicting Tumor Delivery of Macromolecular Therapeutics?Heike E. Daldrup-Link Heike E. Daldrup-Link Author AffiliationsFrom the Department of Radiology, Stanford University, 725 Welch Rd, Room 1665, Stanford, CA 94305-5614; and Cancer Imaging and Early Detection Program, Stanford Cancer Institute, Stanford, Calif.Address correspondence to the author (email: [email protected]).Heike E. Daldrup-Link Published Online:Feb 3 2023https://doi.org/10.1148/rycan.220183MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
